DAVID BATES to Drug Monitoring
This is a "connection" page, showing publications DAVID BATES has written about Drug Monitoring.
Connection Strength
1.393
-
Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther. 2004 Jan; 75(1):110-22.
Score: 0.206
-
A computer-based intervention for improving the appropriateness of antiepileptic drug level monitoring. Am J Clin Pathol. 2003 Mar; 119(3):432-8.
Score: 0.194
-
Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf. 2001 Mar-Apr; 10(2):113-9.
Score: 0.169
-
Improving the use of therapeutic drug monitoring. Ther Drug Monit. 1998 Oct; 20(5):550-5.
Score: 0.143
-
Strategies for physician education in therapeutic drug monitoring. Clin Chem. 1998 Feb; 44(2):401-7.
Score: 0.137
-
Appropriateness of antiepileptic drug level monitoring. JAMA. 1995 Nov 22-29; 274(20):1622-6.
Score: 0.117
-
An intervention to improve the timing of vancomycin levels. Am J Clin Pathol. 2013 Dec; 140(6):801-6.
Score: 0.102
-
What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions. Am J Clin Pathol. 2012 Mar; 137(3):472-8.
Score: 0.091
-
A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. J Am Med Inform Assoc. 2008 Jul-Aug; 15(4):424-9.
Score: 0.069
-
Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 05; 289(9):1107-16.
Score: 0.049
-
Using information technology to screen for adverse drug events. Am J Health Syst Pharm. 2002 Dec 01; 59(23):2317-9.
Score: 0.048
-
Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000 Aug 01; 109(2):87-94.
Score: 0.041
-
The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995 Oct; 21(10):541-8.
Score: 0.029